« Return to News | CROs/Service Providers

RaySearch enters agreement with Chinese distributor

Tuesday, November 29, 2011 12:55 PM
RaySearch Laboratories has entered into an exclusive distribution agreement with the Chinese distributor Kang Li Da Trading, based in Beijing. The agreement means that Kang Li Da will be fully responsible for marketing, sales and service for RaySearch’s proprietary treatment planning system RayStation on the entire Chinese market.
 
China is one of the largest radiation therapy markets globally with approximately 1300 radiation therapy clinics. There is a strong focus on improving healthcare so the radiation therapy sector is growing very rapidly and the number of clinics is expected to increase to 2,000 in less than five years. RayStation is pending regulatory clearance in China and the approval process is expected to last approximately a year and a half.
 
Kang Li Da was founded in 1996 and is a leading distributor of radiation therapy equipment in China. The company has approximately 20 employees and represents a wide range of international radiation therapy equipment suppliers serving more than 500 customers.
 
“China is the fastest growing radiation therapy market so this agreement is extremely important to us. Kang Li Da is a highly experienced distributor of radiation therapy equipment with a broad geographical coverage and excellent track record. We are very excited that they have selected to work exclusively with us within treatment planning and we are looking forward to work closely together to establish RayStation as a leading product on the Chinese market," said Johan Löf, CEO of RaySearch.
Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.